eNcounterView vs Viz.ai
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
eNcounterView
A video conferencing tool for the medical community, enabling remote consultations and real-time sharing of patient data. It aims to make healthcare more accessible by connecting patients with providers.
- Video conferencing for medical use
- Patient-provider connections
- Real-time medical data sharing
- Remote consultations
- Integrated with eNcounter suite
Read full descriptionHide full description
GlobalMed's eNcounterView is a lightweight video conferencing solution designed specifically for the needs of the medical community. Working as a standalone application or integrated into the eNcounter application suite, eNcouterView is used to connect patients with providers. Enabling real-time sharing of medical data, eNcounterView is supported by RTC technologies to facilitate remote consultations and expand upon GlobalMed's mission of making healthcare accessible to all.
Viz.ai
This AI-powered telehealth platform assists clinicians in detecting critical diseases like stroke through advanced imaging analysis. It automates workflows and provides mobile imaging with HIPAA-compliant messaging to synchronize care across specialties.
- AI-powered disease detection
- Automated CT perfusion imaging
- Mobile imaging capabilities
- HIPAA-compliant messaging
- Synchronized clinical workflows
- Remote installation
Read full descriptionHide full description
A Telehealth Platform from the World’s Leading AI Healthcare Company. Viz.ai, which uses artificial intelligence to detect diseases like large vessel occlusions and intracerebral hemorrhages, advanced imaging to automate CT perfusion. Viz.ai also provides mobile imaging and HIPAA-compliant messaging to help synchronize workflow across multiple specialties for diseases like stroke. Fast and easy to install remotely, our plug-and-play solution is designed to help clinical teams during these challenging times. Viz LVO, Viz CTP and Viz ICH are regulated as a medical device and intended for use by trained clinicians. Indications for use are available here: https://www.viz.ai/indications-for-use/
Screenshots
Verdict
The clearest difference is review sentiment: eNcounterView at 100% against Viz.ai's 14%. eNcounterView also leads on rating (5.0 vs 4.2) and iOS requirement (11.0 vs 17.0). Viz.ai's advantage is update cadence (fortnightly vs every 9 months) and ratings volume (36 vs 2). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
eNcounterView holds the better App Store score, 5.0 against 4.2. That said, the two scores are not equally well evidenced: Viz.ai has 36 ratings behind it against 2, so its average is the more settled of the two. Written reviews point the same way: 100% of eNcounterView's written reviews are positive against 14% of Viz.ai's.
eNcounterView ships an update every 9 months, Viz.ai fortnightly. The most recent releases landed on June 1, 2026 and September 16, 2026 respectively.
| Parameter | eNcounterView | Viz.ai |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (2 ratings) — better | 4.2 (36 ratings) |
| Positive reviews | 100.0% of reviews — better | 14.3% of reviews |
| Number of ratings | 2 | 36 — better |
| Update frequency | Every 9 months | Fortnightly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 11.0 — better | 17.0 |
| Further details — not scored | ||
| Size | 31 MB | 56 MB |
| Age rating | 12+ | 12+ |
| Developer | GlobalMed | Viz.ai, Inc. |
Customer experience
eNcounterView
Viz.ai
In-app purchases
eNcounterView
No in-app purchases
Viz.ai
No in-app purchases
